Fidelity International’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
11,831
-1,264
-10% -$180K ﹤0.01% 813
2025
Q4
$2.18M Buy
+13,095
New +$2.19M ﹤0.01% 764
2024
Q2
Sell
-5,782
Closed -$429K 969
2024
Q1
$429K Buy
+5,782
New +$428K ﹤0.01% 770

Other funds holding ALAB

Fidelity International's ALAB Position: Q1 2026 in Review

Fidelity International reduced its Astera Labs (ALAB) stake by 9.7% in Q1 2026, selling an estimated $180K and leaving 11,831 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Fidelity International first reported a position in ALAB in Q1 2024 and has held it in 3 quarters since. The position peaked at $2.18M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Fidelity International held 11,831 shares of Astera Labs worth $1.3M as of Q1 2026.
  • Fidelity International sold 1,264 Astera Labs shares in Q1 2026, an estimated $180K.
  • Astera Labs made up ﹤0.01% of Fidelity International's portfolio in Q1 2026, its #813 holding.
  • Fidelity International first reported a position in Astera Labs in Q1 2024 and has held it in 3 quarters since.
  • Fidelity International's Astera Labs position peaked at $2.18M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.